Volume 3, 1999 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Issues and Opportunities: Compounding for Dentistry
Marek Cindy L
|
Jan/Feb 1999
Pg. 4
|
Compounding Mouthwashes and Rinses for Oral Ulcerations
Paoletti James E, McCord Kayda
|
Jan/Feb 1999
Pg. 8
|
Mouthwash/Gargle Formulation No. 1
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Mouthwash/Gargle Formulation No. 2
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Mouthwash/Gargle Formulation No. 3
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Toothgel Vehicle
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 13
|
Toothpaste Vehicle
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 13
|
Oral Ulceration Mouthwash
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 10
|
Mouthwash, Toothpaste and Toothgel Vehicles
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12-13
|
Toxicity of Amalgams
Fenrich Jon
|
Jan/Feb 1999
Pg. 14
|
A Brief Look at the History of Oral Hygiene
Capps Shelly
|
Jan/Feb 1999
Pg. 17
|
Dental Compounding in Denmark
Petersen Jens Kelsen
|
Jan/Feb 1999
Pg. 18-19
|
The Basics of Compounding: Compounding Ointments and Pastes
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 22-24
|
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 25-29
|
Coenzyme Q10: It's Everywhere
Hudson Sonora
|
Jan/Feb 1999
Pg. 30-33
|
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche
Roentsch George
|
Jan/Feb 1999
Pg. 32
|
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
|
Jan/Feb 1999
Pg. 34-35
|
Audit Problems for Compounding Pharmacies
Heckman H Edward
|
Jan/Feb 1999
Pg. 36-37
|
HRT Marketing Tip
|
Jan/Feb 1999
Pg. 37
|
Ringworms in Cats
Franck Paul W, Allen Cheryl, Thomasson Alex
|
Jan/Feb 1999
Pg. 38
|
Profile of a Practice
Davis Jeanie Lerche
|
Jan/Feb 1999
Pg. 39
|
Dental Cavity Varnish
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 42
|
Dental Chemical Curettage Agent
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 43
|
Dental Pressure Indicating Paste (PIP)
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 44
|
Fluoride Lozenges
Mason Dave
|
Jan/Feb 1999
Pg. 45
|
Gag Tablet
Ford Peter R
|
Jan/Feb 1999
Pg. 46
|
Gum Massage Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 47
|
Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint
Ford Peter R
|
Jan/Feb 1999
Pg. 48
|
Misoprostol Mucoadhesive Anesthetic Powder
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 49
|
Potassium Nitrate Desensitizing Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 50
|
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 51
|
Antioxidants, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 52-55
|
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 56-57
|
Calculations
Prince Shelly J
|
Jan/Feb 1999
Pg. 58
|
Stability of Four Commercial Products Delivered by Mail Order
Hadzija Boka W, Shrewsbury Robert P
|
Jan/Feb 1999
Pg. 59-63
|
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W
|
Jan/Feb 1999
Pg. 64-66
|
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature
Lieu Cynthia L, Chin Alfred, Gill Mark A
|
Jan/Feb 1999
Pg. 67-68
|
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis
Milner Martin
|
Mar/Apr 1999
Pg. 76-79
|
Male Impotency and the Compounding Pharmacist
Preckshot John
|
Mar/Apr 1999
Pg. 80-83
|
Medication Combinations for Penile Injections
Preckshot John
|
Mar/Apr 1999
Pg. 81
|
Complementary Medical Approaches to Benign Prostatic Hyperplasia
Meletis Chris D
|
Mar/Apr 1999
Pg. 85-87
|
Natural Testosterone: Hormone of the Heart
Wright Jonathan V, Lenard Lane
|
Mar/Apr 1999
Pg. 88-98
|
Use of Saw Palmetto and Pygeum in Men
Weise Gill Sr
|
Mar/Apr 1999
Pg. 99-100
|
Case Report: Testosterone Supplementation in a Vasectomy Patient
Jagodzinski Pat
|
Mar/Apr 1999
Pg. 101
|
An Aftershave Lotion for Pseudofolliculitis Barbae
Kloesel Lawson
|
Mar/Apr 1999
Pg. 102-103
|
Compounding for Athletes: A Primer for Rookies
Letendre Mark, Hudson Sonora
|
Mar/Apr 1999
Pg. 104-106
|
Book Reviews
Reed-Kane Dana
|
Mar/Apr 1999
Pg. 107-108
|
Natural HRT: Corrective Measures When the System Goes Down
Ford Gina
|
Mar/Apr 1999
Pg. 109
|
The Basics of Compounding: Compounding Creams and Lotions
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 111-115
|
Profile of a Practice
Davis Jeanie Lerche
|
Mar/Apr 1999
Pg. 116-117
|
Tips for Collecting Mortars and Pestles
Almquist Allen F III
|
Mar/Apr 1999
Pg. 118-120
|
Personal Computing: Take Care When Choosing a Computer Consultant
Goldsborough Reid
|
Mar/Apr 1999
Pg. 122-123
|
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 126-127
|
Marketing Tip: Locator Maps
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 127
|
Athletic-Analgesic Rub
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 130
|
Dehydroepiandrosterone 50-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 131
|
Minoxidil 3% and Finasteride 0.1% Topical Liquid
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 132
|
Piroxicam 0.5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 133
|
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 134
|
Sildenafil Citrate 25-mg Sublingual Troches
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 135
|
Special Aftershave Preparations
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 136
|
Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 137
|
Testosterone 10-mg Troches
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 138
|
Testosterone 10-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 139
|
Preservatives, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 142-143
|
Calculations
Prince Shelly J
|
Mar/Apr 1999
Pg. 145
|
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 146-147
|
Analysis of Extemporaneous Alprostadil Formulations
Sarver Jeffrey G, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
|
Mar/Apr 1999
Pg. 148-155
|
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags
White C Michael, Quercia Robert
|
Mar/Apr 1999
Pg. 156-157
|
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Gupta Vishnu D
|
Mar/Apr 1999
Pg. 158-159
|
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1
Foldvari Marianna, Oguejifor Cosmas
|
Mar/Apr 1999
Pg. 160-163
|
Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP
Allen Loyd V Jr
|
May/Jun 1999
Pg. 172-175
|
Call of the Wild: Compounding for Zoos and Exotics
Hudson Sonora
|
May/Jun 1999
Pg. 176-179
|
Improving Profitability with Veterinary Compounding
Bradley Earl W “Bill”
|
May/Jun 1999
Pg. 180-181
|
Compounding for Creatures: What Works
Davis Jeanie Lerche
|
May/Jun 1999
Pg. 182-185
|
The Top Ten Veterinary Compound Preparations
Allen Loyd V Jr
|
May/Jun 1999
Pg. 183
|
Veterinary Flavor Suggestions
Paoletti James E
|
May/Jun 1999
Pg. 186-187
|
When is Compounding for Animals Legal?
Siegner A Wes Jr
|
May/Jun 1999
Pg. 188-191
|
Use of Fenbendazole in Treating Trichuriasis in Colobus Monkeys
Carr Randy S, Aguilar Roberto F, Carr Lisa L
|
May/Jun 1999
Pg. 193
|
Returning to our Roots
Simmons Chris
|
May/Jun 1999
Pg. 194-195
|
Value and Pricing: Figuring Out What You're Worth
Capps Shelly
|
May/Jun 1999
Pg. 197-199
|
Marketing Tip: Teachable Moments: A Simple Concept
Reed-Kane Dana, Capps Shelly
|
May/Jun 1999
Pg. 199
|
The BPS Pharmacy Specialty Certification Program
Bertin Richard J
|
May/Jun 1999
Pg. 200-203
|
Compounding for Athletes: Tips for Making the Team
Hudson Sonora
|
May/Jun 1999
Pg. 206-208
|
The Basics of Compounding: Compounding Powder-Filled Capsules
Allen Loyd V Jr
|
May/Jun 1999
Pg. 209-215
|
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill
Allen Loyd V Jr
|
May/Jun 1999
Pg. 215
|
Amitriptyline HCl 1-mg/mL Oral Liquid and Gel
Allen Loyd V Jr
|
May/Jun 1999
Pg. 218
|
Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats
Allen Loyd V Jr
|
May/Jun 1999
Pg. 219
|
General Sulfonamide 150-mg/mL Suspension
Allen Loyd V Jr
|
May/Jun 1999
Pg. 220
|
Nonaqueous Nonoleaginous Paste Base
Allen Loyd V Jr
|
May/Jun 1999
Pg. 221
|
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs
Allen Loyd V Jr
|
May/Jun 1999
Pg. 222
|
Progesterone 100-mg/mL Veterinary Injection
Allen Loyd V Jr
|
May/Jun 1999
Pg. 223
|
Sulfadiazine Sodium 333-mg/mL and Pyrimethamine 16.7-mg/mL Oral Liquid
Ahl Harvey
|
May/Jun 1999
Pg. 224
|
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Allen Loyd V Jr
|
May/Jun 1999
Pg. 225
|
Veterinary Electrolyte Injection
Ahl Harvey
|
May/Jun 1999
Pg. 226
|
Veterinary Phenobarbital 22-mg/mL Oral Liquid
Ahl Harvey
|
May/Jun 1999
Pg. 227
|
Sweetening Agents, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 1999
Pg. 228-231
|
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1999
Pg. 232-233
|
Calculations
Prince Shelly J
|
May/Jun 1999
Pg. 234
|
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride
Riggs Robert M, English Brett A, Webster Andrew A, McGuire J Michael, Riordan James M, Worthington Mary A
|
May/Jun 1999
Pg. 235-238
|
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration
Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
|
May/Jun 1999
Pg. 241-244
|
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography
Gupta Vishnu D
|
May/Jun 1999
Pg. 239-240
|
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Kastango Eric S, Douglass Kate
|
Jul/Aug 1999
Pg. 253-258
|
Green IV Nutritionals
Karolchyk Scott
|
Jul/Aug 1999
Pg. 260-261
|
Sterilization and Depyrogenation Principles and Methods
Akers Michael J
|
Jul/Aug 1999
Pg. 263-269
|
Book Review-The CIVAS Handbook
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 269
|
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines
Lima Hetty A
|
Jul/Aug 1999
Pg. 270-273
|
Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
|
Jul/Aug 1999
Pg. 274-276
|
Marketing Tip: PR Can Help with Image Change and Geographic Expansion
Capps Shelly
|
Jul/Aug 1999
Pg. 277
|
Antique Pharmaceutical Balances
Richardson Charles G
|
Jul/Aug 1999
Pg. 280-283
|
Compounding for Athletes: Common Questions about Sports Medicine
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 285-287
|
Profile of a Practice
Davis Jeanie Lerche
|
Jul/Aug 1999
Pg. 288-290
|
The Basics of Compounding: Compounding Special Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 291-294
|
Capsules with Liquid Fill-Sample-Progesterone 100-mg
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 294
|
Capsules with Semisolid Fill-Sample-Tri-Est
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 294
|
Calcium Levulinate 15-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 298
|
Dextrose 20% and Sodium Chloride 20% Sclerosing Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 299
|
Estradiol 5-mg/mL-in-Oil Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 300
|
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 301
|
Morphine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 302
|
Parenteral Admixture with Y-Site Administration
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 303
|
Tri-Est 2.5-mg/mL Aqueous Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 304
|
Trimethoprim 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 305
|
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 306
|
Veterinary Prochlorperazine and Isopropamide Injection
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 307
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Calculations
Prince Shelly J
|
Jul/Aug 1999
Pg. 311
|
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 312-313
|
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography
Gupta Vishnu D, Pramar Y
|
Jul/Aug 1999
Pg. 314-315
|
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
|
Jul/Aug 1999
Pg. 316-320
|
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations
Garzouzi Victoria L, Reifenrath William G
|
Jul/Aug 1999
Pg. 321-324
|
Interview: Katharina Dalton, MD: Progesterone and Related Topics
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 332-339
|
Finding the Balance
Ford Gina
|
Sep/Oct 1999
Pg. 340
|
Top Ten HRT Compound Preparations
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 342
|
Wilson's Syndrome and T3 Therapy
Milner Martin
|
Sep/Oct 1999
Pg. 344-348
|
Assessment and Management of Thermoregulation
Milner Martin
|
Sep/Oct 1999
Pg. 350-351
|
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS
Ilyia Elias F, McLure Deborah, Farhat Michel Y
|
Sep/Oct 1999
Pg. 352-354
|
Andropause: Annotated Citations from the Literature
Biundo Bruce
|
Sep/Oct 1999
Pg. 355-356
|
Women's Health Book Reviews
Reed-Kane Dana
|
Sep/Oct 1999
Pg. 357-359
|
Planning and Marketing a Natural HRT Patient Seminar
Trent Kerry Cunningham
|
Sep/Oct 1999
Pg. 360-361
|
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars
Capps Shelly
|
Sep/Oct 1999
Pg. 362-363
|
Preventing Leakage in Oil-Filled Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 364
|
Feline Urologic Syndrome and Diet Formulation
Long Scott F
|
Sep/Oct 1999
Pg. 366-367
|
Compounding Practice Structures
Climo Dagmar
|
Sep/Oct 1999
Pg. 368-370
|
Closing in on 2000: Your Y2K Report
Davis Jeanie Lerche
|
Sep/Oct 1999
Pg. 371-374
|
Chemical Facial Peel Formulations: an Overview
Levine Phillip J
|
Sep/Oct 1999
Pg. 375-377
|
Jessner's Solution
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 375
|
Unna's Paste
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 375
|
Baker-Gordon Formula
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 376
|
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids
Glasnapp Andrew
|
Sep/Oct 1999
Pg. 380-381
|
Tamoxifen Citrate Cream 0.1%
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 381
|
Compounding for Athletes: Successful Sports Compounds
Hudson Sonora
|
Sep/Oct 1999
Pg. 382-383
|
The Basics of Compounding: Compounding Gels
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 385-389
|
Lubricating Jelly Formula
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 388
|
Poloxamer Gel Base
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 388
|
Clear Carbomer Gel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 388
|
Piroxicam 0.5% in an Alcoholic Gel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 389
|
Methylcellulose Gels
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 389
|
Pluronic Lecithin Organogel (PLO Gel)
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 389
|
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 392
|
Ethinyl Estradiol 0.2-mg Gelatin Troches
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 393
|
Progesterone 50-mg/mL Topical Gel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 394
|
Progesterone 100-mg/mL Sublingual Drops
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 395
|
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 396
|
Progesterone 10% Topical Cream
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 397
|
Progesterone 200-mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 398
|
Testosterone 1-mg Buccal Troches
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 399
|
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 400
|
Triple Estrogen 2.5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 401
|
Alkalizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 404-405
|
Standard Operating Procedure: Quality Assessment for Injectable Solutions
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 406-407
|
Calculations
Prince Shelly J
|
Sep/Oct 1999
Pg. 408
|
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Webster Kathy D, Al-Achi Antoine, Greenwood Robert
|
Sep/Oct 1999
Pg. 409-411
|
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C
Webster Andrew A, English Brett A, McGuire J Michael, Riggs Robert M, Lander Vickie, Buckle Thomas
|
Sep/Oct 1999
Pg. 412-414
|
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
|
Sep/Oct 1999
Pg. 415-420
|
Book Reviews: Hatherleigh Guide to Psychopharmacology
Reed-Kane Dana
|
Nov/Dec 1999
Pg. 454
|
Book Reviews: Medical Abbreviations: 14,000 Conveniences at the Expense of Communications and Safety
Reed-Kane Dana
|
Nov/Dec 1999
Pg. 454
|
Book Reviews: The Arthritis Cure: The Medical Miracle that Can Halt, Reverse, and May Even Cure Osteoarthritis
Reed-Kane Dana
|
Nov/Dec 1999
Pg. 438
|
Erratum: Stability of an Extemporaneously
Formulated Levothyroxine Sodium Syrup
Compounded from Commercial Tablets
(IJPC 1997:1(1):60-64)
|
Nov/Dec 1999
Pg. 427
|
Prescription- New Cures for Arthritis.pdf
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 427
|
Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional
Pournadeali Kasra
|
Nov/Dec 1999
Pg. 428-433
|
Osteoarthritis: Other Options
Berrettini Lee
|
Nov/Dec 1999
Pg. 433-435
|
Book Reviews: Maximizing the Arthritis Cure: A Step-by-Step Program To Faster, Stronger Healing During Any Stage of the Cure
Reed-Kane Dana
|
Nov/Dec 1999
Pg. 438
|
Electronically Controlled Drug Delivery
Kloesel Lawson
|
Nov/Dec 1999
Pg. 439-440
|
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player
Preckshot John
|
Nov/Dec 1999
Pg. 441
|
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis
Miller DeWayne, Vann Pat, Hudson Sonora
|
Nov/Dec 1999
Pg. 441-442
|
Compounding Radiolabeled Blood Cells for Diagnostic Imaging
Hinkle George H
|
Nov/Dec 1999
Pg. 443-446
|
Extemporaneous Formulations: How to Evaluate HPLC Stability Studies
Chan Debora Schotik
|
Nov/Dec 1999
Pg. 447-451
|
Marketing Tip: Flavors: Target Marketing to Doctors and Patients
Capps Shelly
|
Nov/Dec 1999
Pg. 454
|
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care
Davis Jeanie Lerche
|
Nov/Dec 1999
Pg. 455-456
|
Independent Pharmacists Score High with Consumers
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 457
|
When Problem Audits Strike
Heckman H Edward
|
Nov/Dec 1999
Pg. 458-459
|
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 461-465
|
Linguet Base (Soft Lozenge)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Sorbitol Based Hard Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Sucrose Based Hard Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 462
|
Polyethylene Glycol (PEG) Troches (Soft Lozenges)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 463
|
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 463
|
Chewable Lozenges
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 464
|
Capsicum and Capsaicin Formulas
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 468
|
DMSO 70% Topical Solution
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 469
|
Glucosamine HCl 600-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 470
|
Indomethacin 4% Topical Spray
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 471
|
Iontophoresis Solutions for Arthritis
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 472
|
Ketoprofen 2.5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 473
|
Methotrexate 2.5-mg/5-mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 474
|
Methyl Salicylate and Menthol Analgesic Stick
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 475
|
Piroxicam 1% Alcoholic Gel
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 476
|
Ultrasonic Preparations for Arthritis
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 477
|
Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 479
|
Calculations
Prince Shelly J
|
Nov/Dec 1999
Pg. 487
|
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure
Allen Loyd V Jr
|
Nov/Dec 1999
Pg. 488-489
|
Calamine Lotion: Experimenting with a New Suspending Agent
Al-Achi Antoine, Greenwood Robert, Akin-Isijola Austin, Bullard Jenny
|
Nov/Dec 1999
Pg. 490-492
|
Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations
Maget Henri J R
|
Nov/Dec 1999
Pg. 493-495
|
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A, Fuhram L Clifton
|
Nov/Dec 1999
Pg. 496-500
|
Return to Top |